Sperlágh Beáta, Szabó Gábor, Erdélyi Ferenc, Baranyi Mária, Vizi E Sylvester
Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest POB 67, Hungary.
Br J Pharmacol. 2003 Jun;139(3):623-33. doi: 10.1038/sj.bjp.0705285.
(1) Here, we investigated how nucleotides and nucleosides affect the release of tritiated purines and endogenous adenosine 5'-triphosphate (ATP) from superfused rat hippocampal slices. (2) ATP elicited concentration-dependent [(3)H]purine efflux from slices preloaded with [(3)H]adenosine. High-performance liquid chromatography analysis of the effluent showed that the tritium label represented the whole set of adenine nucleotides and nucleosides, and ATP significantly increased the outflow of [(3)H]ATP. (3) Adenosine 5'-diphosphate, adenosine, uridine, uridine 5'-triphosphate, alpha,beta-methylene-ATP and 3'-O-(4-benzoylbenzoyl)-ATP were also active in eliciting [(3)H]purine release. Adenosine (300 micro M) also evoked endogenous ATP efflux from the hippocampal slices. (4) Reverse transcription-coupled-polymerase chain reaction analysis revealed that mRNAs encoding a variety of P2X and P2Y receptor proteins are expressed in the rat hippocampus. Nevertheless, neither P2 receptor (i.e. pyridoxal-5-phosphate-6-azophenyl-2',4'-disulphonic acid, 30 micro M, suramin, 300 micro M and reactive blue 2, 10 micro M), nor adenosine receptor (8-cyclopentyl-1,3-dipropylxanthine, 250 nM and dimethyl-1-propargylxanthine, 250 nM) antagonists modified the effect of ATP (300 micro M) to evoke [(3)H]purine release. (5) The nucleoside transport inhibitors, dipyridamole (10 micro M), nitrobenzylthioinosine (10 micro M) and adenosine deaminase (2-10 U ml(-1)), but not the ecto-adenylate kinase inhibitor diadenosine pentaphosphate (200 micro M) significantly reduced ATP-evoked [(3)H]purine efflux. (6) In summary, we found that ATP and other nucleotides and nucleosides promote the release of one another and themselves by the nucleoside transport system. This action could have relevance during physiological and pathological elevation of extracellular purine levels high enough to reverse the nucleoside transporter.
(1)在此,我们研究了核苷酸和核苷如何影响从经超灌流的大鼠海马切片中释放的氚标记嘌呤和内源性腺苷 5'-三磷酸(ATP)。(2)ATP 引发了从预先加载有[³H]腺苷的切片中浓度依赖性的[³H]嘌呤流出。对流出物的高效液相色谱分析表明,氚标记代表了整套腺嘌呤核苷酸和核苷,并且 ATP 显著增加了[³H]ATP 的流出。(3)腺苷 5'-二磷酸、腺苷、尿苷、尿苷 5'-三磷酸、α,β-亚甲基-ATP 和 3'-O-(4-苯甲酰苯甲酰基)-ATP 在引发[³H]嘌呤释放方面也有活性。腺苷(300 μM)也引发了海马切片中内源性 ATP 的流出。(4)逆转录-聚合酶链反应分析显示,编码多种 P2X 和 P2Y 受体蛋白的 mRNA 在大鼠海马中表达。然而,P2 受体拮抗剂(即磷酸吡哆醛-5-磷酸-6-偶氮苯基-2',4'-二磺酸,30 μM;苏拉明,300 μM;反应性蓝 2, 10 μM)和腺苷受体拮抗剂(8-环戊基-1,3-二丙基黄嘌呤,250 nM;二甲基-1-丙炔基黄嘌呤,250 nM)均未改变 ATP(300 μM)引发[³H]嘌呤释放的作用。(5)核苷转运抑制剂双嘧达莫(10 μM)、硝基苄硫基肌苷(10 μM)和腺苷脱氨酶(2 - 10 U ml⁻¹),但胞外腺苷酸激酶抑制剂二腺苷五磷酸(200 μM)并未显著降低 ATP 引发的[³H]嘌呤流出。(6)总之,我们发现 ATP 和其他核苷酸及核苷通过核苷转运系统促进彼此以及自身的释放。这种作用在细胞外嘌呤水平生理性和病理性升高到足以逆转核苷转运体时可能具有相关性。